Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546
info@example.com

Related Posts

Products

NEFA

Non-Esterified Fatty Acids (NEFA) can be used for evaluating the metabolic status of people with endocrinopathies. It can be used for the detection of Pheochromocytoma and of glucagon, thyrotropin and andrenocorticotropin secreting tumours. It is also occassionally used for monitoring of control of diabetes mellitus.

Biorex Diagnostics manufactures LDH reagents designed for CA 180/270/400 Furuno/Daytona systems.

Add to Quote

Description

Product Name Details CAT.No Size
NEFA (L.S) Suitable for CA 180/270/400 Furuno/ Daytona Series Reagents BXCF477A R1: 1 x 40ml R2: 1 x 10ml CAL: 1 x 1ml

 

 

Product Description

The Biorex Diagnostics NEFA Assay is a high-quality in vitro diagnostic test designed for the quantitative determination of non-esterified fatty acids (NEFA) in human serum and plasma. NEFA are important metabolic substrates that reflect lipid mobilisation and energy utilisation within the body. Accurate measurement of NEFA levels is essential for evaluating metabolic function and provides valuable insight into conditions such as diabetes, insulin resistance, and endocrine disorders, including hormone-secreting tumours.

The use of validated assays provides an objective assessment of laboratory method performance and is an integral part of good laboratory practice. By incorporating the Biorex NEFA Assay into routine workflows, laboratories can reliably assess metabolic status, detect abnormalities in lipid metabolism, and support clinical decision-making. Monitoring NEFA concentrations is particularly relevant in patients with metabolic syndrome or altered energy balance, where precise and reproducible results are critical for effective patient management and treatment evaluation.

Manufactured under strict quality standards, the Biorex Diagnostics NEFA Assay delivers stable and reproducible performance across multiple testing runs. The enzymatic method ensures high sensitivity, accuracy, and consistency, allowing detection of clinically relevant changes in levels. The assay is fully compatible with automated analyzers such as CA 180/270/400 Furuno/Daytona systems, enabling seamless integration into laboratory workflows and supporting efficient, high-throughput testing environments.

Key Features

  • Quantitative Measurement: Accurate determination in serum and plasma.
  • Clinical Relevance: Supports assessment of metabolic and endocrine disorders, including diabetes and hormone-related conditions.
  • High Sensitivity and Reproducibility: Enzymatic method ensures reliable and consistent results.
  • Metabolic Monitoring: Enables evaluation of lipid mobilisation and treatment response.
  • Automated Analyzer Compatibility: Optimised for CA Furuno/Daytona systems.

Benefits

The Biorex Diagnostics NEFA Assay provides laboratories with a reliable solution for evaluating metabolic status and lipid metabolism. Its precision, sensitivity, and compatibility with automated systems make it an essential tool for clinical laboratories, hospital diagnostics, and research applications, supporting accurate interpretation and high-quality patient care.

Contact Us for more information.

Additional information

Storage

2-8°C